ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 82 filers reported holding ITEOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,646,289 | -17.3% | 150,346 | 0.0% | 0.01% | -25.0% |
Q2 2023 | $1,990,581 | -2.7% | 150,346 | 0.0% | 0.01% | +9.1% |
Q1 2023 | $2,046,209 | -30.3% | 150,346 | 0.0% | 0.01% | -38.9% |
Q4 2022 | $2,936,257 | +2.5% | 150,346 | 0.0% | 0.02% | -5.3% |
Q3 2022 | $2,864,000 | -7.5% | 150,346 | 0.0% | 0.02% | +5.6% |
Q2 2022 | $3,097,000 | -36.0% | 150,346 | 0.0% | 0.02% | -35.7% |
Q1 2022 | $4,838,000 | -30.9% | 150,346 | 0.0% | 0.03% | -17.6% |
Q4 2021 | $7,000,000 | +72.5% | 150,346 | 0.0% | 0.03% | +88.9% |
Q3 2021 | $4,059,000 | +5.3% | 150,346 | 0.0% | 0.02% | +5.9% |
Q2 2021 | $3,856,000 | -25.0% | 150,346 | 0.0% | 0.02% | -22.7% |
Q1 2021 | $5,139,000 | +1.1% | 150,346 | 0.0% | 0.02% | +15.8% |
Q4 2020 | $5,085,000 | +23.0% | 150,346 | -10.3% | 0.02% | +11.8% |
Q3 2020 | $4,134,000 | – | 167,562 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |